Thursday, November 7 |
11:00 am |
Registration and Lunch (Emory Dining Hall) |
|
|
Knowledge of Breast Cancer Pretest (Online) |
|
12:00 pm |
Welcome and Introductions |
Joyce O’Shaughnessy, MD |
Module 1: Breast Carcinogenesis & Management of High-Risk Disease |
Moderator: Joyce O'Shaughnessy, MD |
12:05 pm |
Biology of Breast Carcinogenesis and Key Biologic Pathways |
David M. Euhus, MD, FACS |
12:45 pm |
Pathology of Lobular and Ductal Preneoplasia |
Syed A. Hoda, MD |
1:05 pm |
Risk Assessment and Reduction |
Carol Fabian, MD |
1:35 pm |
Germline Mutations and Management Issues |
Jeffrey Weitzel, MD |
2:10 pm |
Biologic Subtypes and Prognostic Factors |
Anne Moore, MD |
2:35 pm |
Predictive Biomarker Testing |
Soonmyung Paik, MD |
3:20 pm |
Case-Management Discussion |
|
3:35 pm |
Break |
|
Module 2: Breast Imaging |
Moderator: Anne Moore, MD |
3:55 pm |
Early Detection: Mammography and Sonography |
Elizabeth A. Rafferty, MD |
4:25 pm |
Magnetic Resonance Imaging |
Elizabeth A. Rafferty, MD |
4:55 pm |
Clinical Utility of PET Scanning in Breast Cancer Management |
David M. Schuster, MD |
5:20 pm |
Case-Management Discussion |
|
5:45 pm |
Adjourn |
|
6:00 pm |
Dinner With the Experts (Emory Dining Hall) Non-CME |
|
7:00 pm |
Meet-the-Faculty Case Discussion Non-CME |
|
|
|
|
Friday, November 8 |
Module 3: Breast Surgery |
Moderator: Eleftherios Mamounas, MD |
7:00 am |
Registration and Continental Breakfast (Amphitheatre Prefunction) |
|
7:30 am |
History of the Pivotal NSABP Trials |
Eleftherios Mamounas, MD, MPH, FACS |
8:00 am |
Surgical Pathology Issues of Practical Importance |
Syed A. Hoda, MD
Anne Moore, MD |
8:30 am |
Primary Surgical Considerations |
Eleftherios Mamounas, MD, MPH, FACS |
9:00 am |
Break |
|
9:20 am |
Management of Rare and Male Breast Cancers and Benign Breast Conditions |
David M. Euhus, MD, FACS |
10:00 am |
The Role Of Sentinel Lymph Node Biopsy and Axillary Dissection |
Anees B. Chagpar MD, MSc, MA, MPH, FRCS(C), FACS |
10:35 am |
Breast Reconstruction: Current Strategies and Future Opportunities |
Hani Sbitany, MD |
11:10 am |
Case-Management Discussion |
|
11:35 am |
Lunch (Emory Dining Hall) |
|
Module 4: Breast Radiation Therapy |
Moderator: Lori J. Pierce, MD, FASTRO |
12:35 pm |
Postmastectomy Radiation Therapy and Issues in Treatment Planning |
Lori J. Pierce, MD, FASTRO |
1:15 pm |
DCIS and Breast-Conserving Therapy for Early-Stage Disease |
Lawrence J. Solin, MD, FACR, FASTRO |
1:50 pm |
Accelerated Radiation Treatment for Early-Stage Breast Cancer |
Douglas Arthur, MD |
2:20 pm |
Case-Management Discussion |
|
Module 5: Adjuvant Chemotherapy and Endocrine Therapy |
Moderator: Joyce O'Shaughnessy, MD |
2:35 pm |
Considerations in Adjuvant Chemotherapy |
Joyce O’Shaughnessy, MD |
3:35 pm |
Break |
|
3:55 pm |
Emerging Therapies for Triple-Negative Breast Cancer |
Joseph Sparano, MD |
4:30 pm |
Matching Evolving Molecular Diagnostics with Novel Therapeutic Agents |
Pamela Munster, MD |
4:50 pm |
Case-Management Discussion |
|
5:30 pm |
Adjourn |
|
6:00 pm |
Dinner With the Experts (Emory Dining Hall) Non-CME |
|
7:00 pm |
Meet-the-Faculty Case Discussion Non-CME |
|
|
|
|
Saturday, November 9 |
Module 5: Adjuvant Chemotherapy and Endocrine Therapy (Cont.) |
Moderator: Joyce O'Shaughnessy, MD |
7:00 am |
Registration and Continental Breakfast (Ampitheater Prefunction) |
|
7:30 am |
Adjuvant Endocrine Therapy for Premenopausal Hormone Receptor–Positive Breast Cancer |
Joyce O’Shaughnessy, MD |
8:00 am |
Adjuvant Endocrine Therapy for Postmenopausal Hormone Receptor–Positive Breast Cancer |
William J. Gradishar, MD, FACP, FASCO |
8:40 am |
Locally Advanced Breast Cancer: Systemic and Local Therapy |
Joseph Sparano, MD |
9:20 am |
Break |
|
9:40 am |
Weight Loss and Exercise |
Anne McTiernan, MD, PhD |
10:00 am |
Emesis and Myelosuppression |
Frankie Ann Holmes, MD, FACP |
10:30 am |
Case-Management Discussion |
|
Module 6: Treatment of HER2-Positive Disease |
Moderator: William J. Gradishar, MD, FACP |
11:00 am |
Treatment of Early-Stage HER2-Positive Breast Cancer |
Edward Romond, MD |
11:30 am |
Management of HER2-Positive Metastatic Breast Cancer and Novel Investigational Strategies |
William J. Gradishar, MD, FACP |
12:05 pm |
Case-Management Discussion |
|
12:30 pm |
Lunch (Emory Dining Hall) |
|
Module 7: Systemic Treatment of Advanced/Metastatic Disease |
Moderator: Joyce O'Shaughnessy, MD |
1:30 pm |
Hormone-Dependent Metastatic Breast Cancer |
Ruth O'Regan, MD |
2:00 pm |
Bone Health, Fatigue, and Cognitive Dysfunction |
Hope S. Rugo, MD |
2:40 pm |
Hormone-Independent Metastatic Breast Cancer |
Allison Stopeck, MD |
3:20 pm |
Alternative and Complementary Therapies |
Dawn Hershman, MD, MS |
3:45 pm |
Case-Management Discussion |
|
4:05 pm |
Break |
|
Module 8: Organ-Targeted Treatment of Metastatic Disease |
Moderator: Joyce O'Shaughnessy, MD |
4:25 pm |
Managing CNS Disease |
Paul W. Sperduto, MD, MPP |
4:55 pm |
Managing Skeletal Metastases |
Allison Stopeck, MD |
5:25 pm |
Case-Management Discussion |
|
5:45 pm |
Adjourn |
|
6:00 pm |
Dinner With the Experts (Emory Dining Hall) Non-CME |
|
7:00 pm |
Meet-the-Faculty Case Discussion Non-CME |
|
|
|
|
Sunday, November 10 |
7:30 am |
Registration and Continental Breakfast (Ampitheater Prefunction) |
|
8:00 am |
The Art of Managing Metastatic Breast Cancer |
Melody Cobleigh, MD |
Module 9: Toxicity Management, Pregnancy, and Risk Reduction |
Moderator: Frankie Ann Holmes, MD |
8:35 am |
Management of Therapy-Related Symptomatic Toxicities |
Charles Loprinzi, MD |
9:15 am |
Breast Cancer, Fertility and Pregnancy |
Karin Hahn, MD, MSc, MPH, MSc (EBHC) |
9:45 am |
New Insights Into Breast Cancer Risk Reduction |
Rowan Chlebowski, MD, PhD |
10:05 am |
Break |
|
Module 10: End of Life and Survivorship |
Moderator: Frankie Ann Holmes, MD |
10:20 am |
What Does Breast Cancer Treatment Cost and What is it Worth? |
Elena Elkin, PhD |
10:45 am |
Follow-up Issues for Patients With Early-Stage Breast Cancer |
Joyce O'Shaughnessy, MD |
11:10 am |
Case-Management Discussion |
|
11:45 am |
Wrap-up and Adjourn |
|